<DOC>
	<DOCNO>NCT00151827</DOCNO>
	<brief_summary>This study hypertensive patient mild moderate renal impairment . The antihypertensive efficacy olmesartan medoxomil compare losartan .</brief_summary>
	<brief_title>Olmesartan Medoxomil Hypertension Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Mean sit BP prior randomization 140180/90109 mmHg ; Renal impairment prior randomization mild ( 50 ≤ CLcr ≥ 80 mL/min ) moderate ( 30 ≤ CLcr ≥50 mL/min ) severity Malignant hypertension sit BP great 180/109 mmHg ; Severe heart failure , severe renal disease ; Recent history myocardial infarction , stroke transient ischemic attack ; History , clinical current evidence significant gastrointestinal , respiratory , hematological , metabolic , immunological underlying disease opinion investigator would interfere patient 's participation trial ; Hypersensitivity contraindication ARBs ACE inhibitor cross allergy ; Treatment disallow medication ; Pregnant breastfeeding female females childbearing potential without adequate contraception ; History drug and/or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>